Skip to content
Neurescue logo — Saving Hearts and Minds - Cardiovascular devices to improve...

Neurescue

Saving Hearts and Minds - Cardiovascular devices to improve outcomes for emergency patients

Founded 2014 Denmark Denmark 15 employees Series A Total: $76.00M Biotechnology, Health Care +1

General Information

Company Name Neurescue
Founded Year 2014
Location Denmark Denmark
Founders / Decision Makers
Team member
Employees 15
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Neurescue. To contact Neurescue, visit neurescue.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Neurescue compare?

A PDF of Neurescue and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Neurescue soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Neurescue

Neurescue is a Denmark-based startup with a mission to revolutionize emergency patient care with its innovative cardiovascular devices. The company's groundbreaking FDA-cleared intelligent balloon system is designed to improve outcomes for emergency patients, embodying the ethos of "Saving Hearts and Minds." Neurescue has distinguished itself within the biotechnology and healthcare industries, attracting significant attention and support from investors. The startup recently secured a kr50.00M Series A investment on 02 February 2024, with backing from West Hill Capital. This substantial investment reflects growing confidence in Neurescue's potential to make a meaningful impact in the healthcare sector. Neurescue's focus on cardiovascular innovation aligns with the increasing demand for advanced medical solutions, especially in emergency scenarios. The company's dedication to improving patient outcomes positions it as a compelling opportunity for further growth and development. Overall, Neurescue's recent investment milestone underscores its potential to drive positive change in emergency healthcare, signaling an exciting trajectory for the company as it continues to advance its life-saving technologies.

Business keywords: Medical devices, Cardiovascular, Emergency care, Denmark-based company, SafeREBOA device, Aortic occlusion catheter, Clinical utility, Intelligent procedures, Innovative medical technology

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A kr50.00M 1
West Hill Capital
02 Feb 2024
Seed Round Undisclosed 1
Nina Ventures
31 Mar 2020
Venture Round kr26.00M -
07 Apr 2017
Venture Round Undisclosed 1
Seed Capital
01 Jan 2014

Neurescue Alternatives & Competitors

View All Alternatives
Neurescue vs

Advancing cardiovascular health with innovative, cost-effective medical devices that enhance patient...

Series C
Biotechnology, Health Care
Neurescue vs
Procyrion, Inc.
Procyrion, Inc. United States

Developing catheter-based circulatory support devices to address the needs of heart failure and kidn...

Series E
28 employees
Health Care, Medical Devices
Neurescue vs

Dedicated to natural breathing by empowering patients to wean off mechanical ventilation and breathe...

Venture round
58 employees
Biotechnology, Health Care

FAQ About Neurescue

Saving Hearts and Minds - Cardiovascular devices to improve outcomes for emergency patients
Neurescue was founded in 2014.
Neurescue is headquartered in Denmark.
Neurescue operates in Biotechnology, Health Care and Medical Devices. Its work centres on Medical devices, Cardiovascular, Emergency care and Denmark-based company.
Neurescue has approximately 15 employees.
Neurescue has completed 4 funding rounds, raising a total of $76.00M. The latest funding stage is Series A.
Top alternatives and competitors to Neurescue include BioStable, Procyrion, Inc., Lungpacer Medical, Protembis GmbH, RTM Vital SIgns. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neurescue and BioStable are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neurescue, https://www.bouncewatch.com/company/neurescue, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout